DHA

Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.

Cross Reference

Introduction

To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with DHA?

DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with DHA

MeSH term MeSH ID Detail
Plaque, Amyloid D058225 19 associated lipids
Eye Abnormalities D005124 7 associated lipids
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma D054218 5 associated lipids
Chondrodysplasia Punctata, Rhizomelic D018902 4 associated lipids
Chronic Pain D059350 5 associated lipids
Neuroaxonal Dystrophies D019150 3 associated lipids
Spinocerebellar Ataxias D020754 4 associated lipids
Paracoccidioidomycosis D010229 2 associated lipids
Leukemia, Prolymphocytic D015463 2 associated lipids
Hydroa Vacciniforme D006837 1 associated lipids
Trophoblastic Tumor, Placental Site D018245 1 associated lipids
Phenylketonuria, Maternal D017042 1 associated lipids
Refsum Disease, Infantile D052919 1 associated lipids
Pulmonary Valve Stenosis D011666 1 associated lipids
Cerebrovascular Trauma D020214 1 associated lipids
Histiocytoma, Malignant Fibrous D051677 1 associated lipids
Decapitation D049248 2 associated lipids
Communication Disorders D003147 1 associated lipids
Geographic Atrophy D057092 1 associated lipids
Lordosis D008141 1 associated lipids
Per page 10 20 50 100 | Total 240

PubChem Associated disorders and diseases

What pathways are associated with DHA

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with DHA?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with DHA?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with DHA?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with DHA?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with DHA?

Mouse Model

Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).

Transgenic Model

Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).

Animal Disease Models

Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with DHA

Download all related citations
Per page 10 20 50 100 | Total 7336
Authors Title Published Journal PubMed Link
Brouwer IA et al. Association between n-3 fatty acid status in blood and electrocardiographic predictors of arrhythmia risk in healthy volunteers. 2002 Am. J. Cardiol. pmid:11867059
Birch EE et al. A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. 2002 Am. J. Clin. Nutr. pmid:11864865
Champoux M et al. Fatty acid formula supplementation and neuromotor development in rhesus monkey neonates. 2002 Pediatr. Res. pmid:11861930
Qi K et al. Long-chain polyunsaturated fatty acid accretion in brain. 2002 Curr Opin Clin Nutr Metab Care pmid:11844978
Takeuchi T et al. Influence of a dietary n-3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat. 2002 Behav. Brain Res. pmid:11844586
Marchioli R et al. Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. 2001 Lipids pmid:11837985
McLennan PL Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. 2001 Lipids pmid:11837983
Bell JG et al. Substituting fish oil with crude palm oil in the diet of Atlantic salmon (Salmo salar) affects muscle fatty acid composition and hepatic fatty acid metabolism. 2002 J. Nutr. pmid:11823582
Buznikov GA et al. [Cholinergic regulation of the sea urchin embryonic and larval development]. 2001 Ross Fiziol Zh Im I M Sechenova pmid:11822358
Qi B et al. Identification of a cDNA encoding a novel C18-Delta(9) polyunsaturated fatty acid-specific elongating activity from the docosahexaenoic acid (DHA)-producing microalga, Isochrysis galbana. 2002 FEBS Lett. pmid:11801246
Ratledge C et al. Production of docosahexaenoic acid by Crypthecodinium cohnii grown in a pH-auxostat culture with acetic acid as principal carbon source. 2001 Lipids pmid:11795857
Schiefermeier M and Yavin E n-3 Deficient and docosahexaenoic acid-enriched diets during critical periods of the developing prenatal rat brain. 2002 J. Lipid Res. pmid:11792731
Whelan J Targeted taxane therapy for cancer. 2002 Drug Discov. Today pmid:11790612
Neschen S et al. Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content. 2002 Am. J. Physiol. Endocrinol. Metab. pmid:11788372
Gibson RA and Makrides M Long-chain polyunsaturated fatty acids in breast milk: are they essential? 2001 Adv. Exp. Med. Biol. pmid:11787705
Agostoni C et al. Prolonged breast-feeding (six months or more) and milk fat content at six months are associated with higher developmental scores at one year of age within a breast-fed population. 2001 Adv. Exp. Med. Biol. pmid:11787675
Huber T et al. Structure of docosahexaenoic acid-containing phospholipid bilayers as studied by (2)H NMR and molecular dynamics simulations. 2002 J. Am. Chem. Soc. pmid:11782182
Pawlosky RJ et al. Ethanol consumption alters electroretinograms and depletes neural tissues of docosahexaenoic acid in rhesus monkeys: nutritional consequences of a low n-3 fatty acid diet. 2001 Alcohol. Clin. Exp. Res. pmid:11781509
Valenzuela A and Nieto MS [Docosahexaenoic acid (DHA) in fetal development and in infant nutrition]. 2001 Rev Med Chil pmid:11775350
Wu FC et al. Docosahexaenoic acid is superior to eicosapentaenoic acid as the essential fatty acid for growth of grouper, Epinephelus malabaricus. 2002 J. Nutr. pmid:11773511
Hawkes JS et al. Transforming growth factor beta in human milk does not change in response to modest intakes of docosahexaenoic acid. 2001 Lipids pmid:11768164
Bell MV et al. Biosynthesis and tissue deposition of docosahexaenoic acid (22:6n-3) in rainbow trout (Oncorhynchus mykiss). 2001 Lipids pmid:11768160
Reich EE et al. Quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. 2001 Adv. Exp. Med. Biol. pmid:11764949
de Swaaf ME et al. Characterisation of extracellular polysaccharides produced by Crypthecodinium cohnii. 2001 Appl. Microbiol. Biotechnol. pmid:11759692
Siddiqui RA et al. Prevention of docosahexaenoic acid-induced cytotoxicity by phosphatidic acid in Jurkat leukemic cells: the role of protein phosphatase-1. 2001 Biochim. Biophys. Acta pmid:11755213
Noguchi R et al. Dietary effects of bitter gourd oil on blood and liver lipids of rats. 2001 Arch. Biochem. Biophys. pmid:11747298
Petrache HI et al. Structural properties of docosahexaenoyl phospholipid bilayers investigated by solid-state 2H NMR spectroscopy. 2001 J. Am. Chem. Soc. pmid:11741426
Contreras MA et al. Chronic nutritional deprivation of n-3 alpha-linolenic acid does not affect n-6 arachidonic acid recycling within brain phospholipids of awake rats. 2001 J. Neurochem. pmid:11739623
Pradalier A et al. Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placebo. 2001 Cephalalgia pmid:11737007
Fernández-Real JM et al. Circulating granulocyte-macrophage colony-stimulating factor and serum fatty acid composition in men and women. 2001 Metab. Clin. Exp. pmid:11735097
Denys A et al. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase (ERK1/ERK2) signaling in human T cells. 2001 J. Lipid Res. pmid:11734574
Ferdinandusse S et al. Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid. 2001 J. Lipid Res. pmid:11734571
Mizejewski GJ and Pass KA Fatty acids, alpha-fetoprotein, and cystic fibrosis. 2001 Pediatrics pmid:11731663
Das UN et al. Effect of corticosteroids and eicosapentaenoic acid/docosahexaenoic acid on pro-oxidant and anti-oxidant status and metabolism of essential fatty acids in patients with glomerular disorders. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11728172
Salem N et al. Mechanisms of action of docosahexaenoic acid in the nervous system. 2001 Lipids pmid:11724467
Politi L et al. Effects of docosahexaenoic acid on retinal development: cellular and molecular aspects. 2001 Lipids pmid:11724465
Jeffrey BG et al. The role of docosahexaenoic acid in retinal function. 2001 Lipids pmid:11724458
Rousseau D et al. Dietary n-3 polyunsaturated fatty acids affect the development of renovascular hypertension in rats. 2001 Mol. Cell. Biochem. pmid:11716352
Narayanan BA et al. Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. 2001 Int. J. Oncol. pmid:11713597
Strandvik B et al. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. 2001 J. Pediatr. pmid:11713441
Roque ME et al. Effect of surfactants and natural detergents on phosphatidylcholine synthesis in photoreceptor membranes. 2001 Membr Cell Biol pmid:11699863
Wang JY and Saito M Dietary supplementation of N-3 fatty acids and hydroperoxide levels in rat retinas. 2001 Free Radic. Res. pmid:11697133
Helland IB et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. 2001 Pediatrics pmid:11694666
Lampen A et al. Phytanic acid and docosahexaenoic acid increase the metabolism of all-trans-retinoic acid and CYP26 gene expression in intestinal cells. 2001 Biochim. Biophys. Acta pmid:11690641
Fan KW et al. Eicosapentaenoic and docosahexaenoic acids production by and okara-utilizing potential of thraustochytrids. 2001 J. Ind. Microbiol. Biotechnol. pmid:11687930
Politi LE et al. Effect of GDNF on neuroblast proliferation and photoreceptor survival: additive protection with docosahexaenoic acid. 2001 Invest. Ophthalmol. Vis. Sci. pmid:11687549
Dewailly E E et al. Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers. 2001 Am. J. Clin. Nutr. pmid:11684528
Innis SM et al. Are human milk long-chain polyunsaturated fatty acids related to visual and neural development in breast-fed term infants? 2001 J. Pediatr. pmid:11598600
Ruiz-Sanz JI et al. Polyunsaturated fatty acid deficiency during dietary treatment of very long-chain acyl-CoA dehydrogenase deficiency. Rescue with soybean oil. 2001 J. Inherit. Metab. Dis. pmid:11596652
Li QC et al. [Determination of docosahexenoic acid in human serum by capillary gas chromatography]. 1997 Yao Xue Xue Bao pmid:11596318